FDA 483 - Formulation Technology, Inc. - March 21, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Formulation Technology, Inc. in Oakdale, CA, a dietary supplement and drug manufacturer, revealed significant deficiencies across multiple areas of its operations. The firm failed to implement effective contamination prevention measures, exhibited poor quality control unit oversight, and neglected proper equipment calibration and maintenance. Additionally, widespread employee training failures were noted, indicating a serious lack of adherence to current Good Manufacturing Practices.
ID · d454ccf6-c90b-4ed0-ac03-a344f8a633ab